Dapagliflozin ((2S)-1,2-propanediol, hydrate)
CAS: 960404-48-2
Ref. TM-T4460
5mg | 51,00 € | ||
10mg | 66,00 € | ||
25mg | 80,00 € | ||
50mg | 90,00 € | ||
100mg | 113,00 € | ||
500mg | 263,00 € | ||
1ml*10 (DMSO) | 52,00 € |
Información del producto
- BMS-512148 (2S)-1,2-propanediol, hydrate, Dapagliflozin propanediol monohydrate
- (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-<span class="text-smallcaps">D</span>-glucitol (S)-propane-1,2-diol (1:1) monohydrate
- <span class="text-smallcaps">D</span>-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol (1:1), monohydrate
- <span class="text-smallcaps">D</span>-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol, hydrate (1:1:1)
- Dapagliflozin (S)-propylene glycol hydrate
- Dapagliflozin Propylene Glycolate Hydrate
- Edistride
- Farxiga
- Forxiga
Dapagliflozin ((2S)-1,2-propanediol, hydrate) (BMS-512148 (2S)-1,2-propanediol, hydrate) is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2). It is in development for the treatment of type 2 diabetes mellitus (T2DM). It inhibits subtype 2 of the sodium-glucose transport proteins (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney.
Propiedades químicas
Consulta técnica sobre: TM-T4460 Dapagliflozin ((2S)-1,2-propanediol, hydrate)
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.